Protein, Nutrition and Cardiovascular Disease in Stage 5 Chronic Kidney Disease
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT00566670 |
Recruitment Status :
Completed
First Posted : December 3, 2007
Last Update Posted : August 11, 2016
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
National Kidney Foundation guidelines recommend a dietary protein intake of 1.2 grams per kilogram per day (g/kg/d) in hemodialysis patients. However, it is unclear whether consumption of high amounts of protein in dialysis patients has beneficial or harmful nutritional and cardiovascular effects in this population. High protein intake might improve nutritional status, but it has been argued that the state of low muscle mass, small body size and low serum protein levels is not the result of decreased dietary intake, rather a result of hypercatabolism induced by metabolic acidosis, inflammation and oxidative stress.
The specific aims of this study are to examine in a prospective cohort of hemodialysis patients the longitudinal associations of absolute total protein intake or dietary protein intake with muscle mass and arterial stiffness.
Condition or disease |
---|
End Stage Renal Disease |
It is hypothesized that in the dialysis population overall: (1) Protein intake is a major determinant of muscle mass while inflammation, oxidative stress and metabolic acidosis play a lesser role; (2) Malnutrition is not an uremic cardiovascular risk factor hence low protein intake does not cause cardiovascular disease; and (3) In the other extreme, high protein intake is also not a major cause of cardiovascular disease since high serum phosphorus associated with high protein intake can usually be controlled by the use of phosphorus binders in routine clinical practice.
The specific aims of this proposal are to examine in a prospective cohort of hemodialysis patients the longitudinal associations of absolute total protein intake (TPI) in grams/day, or dietary protein intake (DPI) normalized to body weight in grams/kilogram/day) with
- Nutritional status (mid-thigh muscle mass as measured by Magnetic Resonance Imaging ) and functional status (6-min walk) and
- Arterial stiffness (aortic pulse wave velocity)
Understanding the relationship between protein intake with body composition (muscle mass) and intermediate cardiovascular outcomes (arterial stiffness) in stage 5 CKD patients in hemodialysis is of great scientific and practical significance
Study Type : | Observational |
Actual Enrollment : | 145 participants |
Observational Model: | Cohort |
Time Perspective: | Prospective |
Official Title: | Protein Intake, Nutrition and Cardiovascular Disease in Stage 5 Chronic Kidney Disease (CKD) |
Study Start Date : | September 2007 |
Actual Primary Completion Date : | October 2015 |
Actual Study Completion Date : | October 2015 |

Group/Cohort |
---|
Observation (all participants)
Stage 5 Chronic Kidney Disease and hemodialysis patients
|
- Correlation of muscle mass with protein intake [ Time Frame: Baseline and 18 months ]Mid-thigh muscle mass measured by magnetic resonance imaging
- Correlation of arterial stiffness with protein intake [ Time Frame: Baseline and 18 months ]Radial artery stiffness measured by pulse wave velocity and pulse wave assessment
Biospecimen Retention: Samples With DNA
30 ml of blood drawn four times (months 1, 6, 12 and 18) for plasma/serum/DNA samples.
Urine Collection: If patients are making more than ½ cup (200 ml) of urine a day.

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 18 Years and older (Adult, Older Adult) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | No |
Sampling Method: | Non-Probability Sample |
Inclusion Criteria:
- Adult stage 5 chronic kidney disease patients, on dialysis for at least 3 months.
- Urine output > 200 mL/day
Exclusion Criteria:
- Patients with persistent volume overload (substantial pedal edema) despite attempts at achieving dry weight
- Patients with inability to walk or who use a wheel-chair with reduced mid-thigh muscle mass
- Persons with pacemakers, cochlear implants, or other prohibitive conditions for magnetic resonance imaging
- Atrial fibrillation
- Patients who are unlikely or unable (in the opinion of the nephrologists, nurses or dieticians taking care of the patient) to comply with research protocol
- Patients with symptomatic heart failure, current active malignancy (excluding squamous and basal cell skin cancers), active AIDS, chronic lung disease requiring supplemental oxygen therapy and cirrhosis
- Patients enrolled in interventional trials

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00566670
United States, Tennessee | |
Vanderbilt University Medical Centet | |
Nashville, Tennessee, United States, 37232-2372 | |
United States, Utah | |
University of Utah | |
Salt Lake City, Utah, United States, 84112 |
Principal Investigator: | Srinivasan Beddhu, M.D | University of Utah |
Responsible Party: | Srinvasan Beddhu, MD, University of Utah |
ClinicalTrials.gov Identifier: | NCT00566670 |
Other Study ID Numbers: |
IRB_00024816 R01DK077298 ( U.S. NIH Grant/Contract ) |
First Posted: | December 3, 2007 Key Record Dates |
Last Update Posted: | August 11, 2016 |
Last Verified: | August 2016 |
Hemodialysis |
Kidney Diseases Renal Insufficiency, Chronic Kidney Failure, Chronic |
Cardiovascular Diseases Urologic Diseases Renal Insufficiency |